New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149
The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly LLY 1.15%increase; green up pointing triangle…
Tokushima company develops bear repellent spray amid record attack numbers
As Japan grapples with a record number of fatal bear attacks, a small company in Tokushima Prefecture has…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Eli Lilly (LLY) earnings Q3 2025
David Ricks, chief executive officer of Eli Lilly & Co., during a news conference at Generation Park in…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…
Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…
Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell You
ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…